Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.

Abstract

Human breast cell lines are often characterized based on the expression of the cell surface markers CD44 and CD24. CD44 is a type I transmembrane glycoprotein that regulates cell adhesion and cell-cell, as well as cell-extracellular matrix interactions. CD24 is expressed in benign and malignant solid tumors and is also involved in cell adhesion and metastasis. The aim of the present study was to investigate the effects of curcumin on the surface expression of CD44 and CD24 in breast epithelial cell lines. An established breast cancer model derived from the MCF-10F cell line was used. The results revealed that curcumin decreased CD44 and CD24 gene and protein expression levels in MCF-10F (normal), Alpha5 (premalignant) and Tumor2 (malignant) cell lines compared with the levels in their counterpart control cells. Flow cytometry revealed that the CD44+/CD24+ cell subpopulation was greater than the CD44+/CD24- subpopulation in these three cell lines. Curcumin increased CD44+/CD24+ to a greater extent and decreased CD44+/CD24- subpopulations in the normal MCF-10F and the pre-tumorigenic Alpha5 cells, but had no significant effect on Tumor2 cells compared with the corresponding control cells. Conversely, curcumin increased CD44 and decreased CD24 gene expression in MCF-7 breast cancer cells, and decreased CD44 gene expression in MDA-MB-231 cell line, while CD24 was not present in these cells. Curcumin did not alter the CD44+/CD24+ or CD44+/CD24- subpopulations in the MCF-7 cell line. However, it increased CD44+/CD24+ and decreased CD44+/CD24- subpopulations in MDA-MB-231 cells. In breast cancer specimens from patients, normal tissues were negative for CD44 and CD24 expression, while benign lesions were positive for both markers, and malignant tissues were found to be negative for CD44 and positive for CD24 in most cases. In conclusion, these results indicated that curcumin may be used to improve the proportion of CD44+/CD24+ cells and decrease the proportion of CD44+/CD24- cells. Therefore, it may be suggested that curcumin decreased cancerous types of breast cells.

• Authors: Gloria M Calaf, Richard Ponce-Cusi, Jorge Abarca-Quinones
• Journal: Oncology reports (Oncol Rep) Vol. 39 Issue 6 Pg. 2741-2748 (Jun 2018) ISSN: 1791-2431 [Electronic] Greece
• PMID: 29693159 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Biomarkers, Tumor
• CD24 Antigen
• CD24 protein, human
• CD44 protein, human
• Hyaluronan Receptors
• Curcumin

Topics

• Biomarkers, Tumor (genetics, metabolism)
• Breast Neoplasms (drug therapy, genetics, metabolism)
• CD24 Antigen (genetics, metabolism)
• Cell Line, Tumor
• Curcumin (pharmacology)
• Female
• Gene Expression Regulation, Neoplastic (drug effects)
• Humans
• Hyaluronan Receptors (genetics, metabolism)
• MCF-7 Cells